$46.67
Price
$67.6B
Market Cap
19.5
P/E Ratio
13.6
Forward P/E
$2.39
EPS (TTM)
—
Dividend Yield
$539M
Cash
$11.4B
Total Debt
1.45B
Shares Out
$42.20
$109.50
52-Week Range
Institutional Ownership of Boston Scientific Corp
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 720.3K | $31M | $55.98 | -8.24% |
Trading Activity for Boston Scientific Corp
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| BUY | NEW | 720.3K | $31M | $55.98 | |
| SELL | EXIT | — | — | $55.98 | |
| 2026-Q1 | |||||
| SELL | EXIT | — | — | $75.61 | |
| SELL | -48.1% | 104.7K | $7M | $75.61 | |
| 2025-Q4 | |||||
| BUY | +1.4% | 5.4M | $513M | $97.72 | |
| BUY | NEW | 201.7K | $19M | $97.72 | |
| 2025-Q3 | |||||
| BUY | +223.7% | 5.3M | $519M | $103.86 | |
| 2025-Q2 | |||||
| BUY | NEW | 1.6M | $176M | $102.43 | |
| 2020-Q4 | |||||
| SELL | EXIT | — | — | $35.21 | |
| 2020-Q3 | |||||
| SELL | -17.1% | 787.5K | $30M | $38.60 | |
| 2020-Q2 | |||||
| BUY | +726.1% | 950.0K | $33M | $36.22 | |
| 2020-Q1 | |||||
| SELL | EXIT | — | — | $42.22 | |
| BUY | NEW | 115.0K | $4M | $42.22 | |
| 2019-Q3 | |||||
| SELL | -9.1% | 5.0M | $203M | $42.46 | |
| 2019-Q2 | |||||
| BUY | +10.0% | 5.5M | $236M | $38.15 | |
| 2019-Q1 | |||||
| BUY | NEW | 5.0M | $192M | $38.15 | |
| 2018-Q4 | |||||
| SELL | EXIT | — | — | $36.49 | |
| 2018-Q3 | |||||
| SELL | -66.2% | 853.9K | $33M | $34.33 | |
| 2018-Q2 | |||||
| SELL | -35.4% | 2.5M | $83M | $30.09 | |
| 2018-Q1 | |||||
| SELL | -18.2% | 3.9M | $107M | $27.39 | |
Insider Trading for Boston Scientific Corp
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.